...
首页> 外文期刊>Asian Pacific Journal of Cancer Prevention >Comparative Analysis of Modified Liquid-Based Cytology and CytoRich Red Preparation in Assessment of Serous Effusion for Cancer Diagnosis
【24h】

Comparative Analysis of Modified Liquid-Based Cytology and CytoRich Red Preparation in Assessment of Serous Effusion for Cancer Diagnosis

机译:癌症诊断浆膜浆液性浆液性能改性液体细胞学和胞质红色制剂的比较分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: We aimed to compare the cytomorphological diagnosis in serous effusion and quality of backgroundbetween modified liquid-based cytology (modified-LBC) and CytoRich Red (CRR) preservative. Methods: We usedan experimental study design: 110 fresh serous effusions were received from 50 cases negative for malignant effusionsand 60 cases positive for malignant effusions. All fresh serous effusions were processed using both the CRR solutionand the modified-LBC preparation. Blind sample slides were interpreted for cytomorphological diagnosis and thequality of background by 2 cytotechnologists. Result: All cases had the same diagnosis irrespective of the method.There was no statistically significant difference in the cytological diagnosis between the CRR and modified-LBCpreparations (p0.999). The quality of the background smear for the CRR preparation was clean (54%), moderate in42%, and poor in 4%. By comparison, the modified-LBC preparation was clean in 46%, moderate in 47%, and poor in7%. The difference between the quality of background smears between the two methods was not statistically significant(p= 0.527). Conclusion: There was no statistically significant difference in the diagnosis or quality of backgroundbetween CRR and modified-LBC preparations. The serous effusion specimen prepared by modified-LBC solution wasless expensive than CRR. The modified-LBC could be an alternative preparation when commercial preparations aretoo expensive.
机译:目的:我们旨在比较细胞骨髓诊断和体积改性液体型细胞学(改性LBC)和Cytorich Red(CRR)防腐剂的质量。方法:我们曾经使用实验研究设计:110种新鲜浆液发生的50例,恶性生存量和恶性生效阳性为60例。使用CRR溶液和改性的LBC制剂处理所有新鲜的浆液效果。将盲目样品幻灯片解释为细胞形态诊断和背景的特性诊断和2个细胞技术学家。结果:无论方法如何,所有病例都具有相同的诊断。CRR和改性-LBCPRAPERATION之间的细胞学诊断没有统计学差异(p> 0.999)。 CRR制剂的背景涂片的质量清洁(54%),中度为42%,4%差。相比之下,改性-LBC制剂在46%的46%中清洁,中等为47%,差约为7%。两种方法之间的背景涂片质量之间的差异在统计学上没有统计学意义(P = 0.527)。结论:Backgroundween CRR和改性LBC制剂的诊断或质量没有统计学上显着差异。通过改性-1Bc溶液制备的浆液积液标本始于CRR昂贵。当商业制剂aretoo昂贵时,改性的LBC可能是另一种准备。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号